Network Pharmacology-Based Analysis of the Pharmacological Mechanisms of Aloperine on Cardiovascular Disease

Table 1

Target genes of aloperine related with CVD.

Number	Gene ID	Gene symbol	Gene name
1	6530	SLC6A2	Solute carrier family 6 member 2
2	3358	HTR2C	5-Hydroxytryptamine receptor 2C
3	3357	HTR2B	5-Hydroxytryptamine receptor 2B
4	151	ADRA2B	Adrenoceptor alpha 2B
5	146	ADRA1D	Adrenoceptor alpha 1D
6	148	ADRA1A	Adrenoceptor alpha 1A
7	147	ADRA1B	Adrenoceptor alpha 1B
8	5979	RET	Ret proto-oncogene
9	153	ADRB1	Adrenoceptor beta 1
10	766	CA7	Carbonic anhydrase 7
11	761	CA3	Carbonic anhydrase 3
12	765	CA6	Carbonic anhydrase 6
13	771	CA12	Carbonic anhydrase 12
14	23632	CA14	Carbonic anhydrase 14
15	768	CA9	Carbonic anhydrase 9
16	762	CA4	Carbonic anhydrase 4
17	11238	CA5B	Carbonic anhydrase 5B
18	763	CA5A	Carbonic anhydrase 5A
19	1129	CHRM2	Cholinergic receptor muscarinic 2
20	1128	CHRM1	Cholinergic receptor muscarinic 1
21	1814	DRD3	Dopamine receptor D3
22	6532	SLC6A4	Solute carrier family 6 member 4
23	7442	TRPV1	Transient receptor potential cation channel subfamily V member 1
24	760	CA2	Carbonic anhydrase 2
25	6713	SQLE	Squalene epoxidase